Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: a pilot study.

Source:http://linkedlifedata.com/resource/pubmed/id/16080564

Download in:

View as

General Info

PMID
16080564